Correction To: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

Drugs - United Kingdom
doi 10.1007/s40265-018-1034-z
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cytarabine Dose for Acute Myeloid Leukemia

New England Journal of Medicine
Medicine
2011English

Acute Aleukaemic Myeloid Leukaemia

BMJ
1943English

Prognosis in Acute Myeloid Leukaemia.

BMJ
1981English

Cytarabine Induction Followed by Imatinib Post-Induction Therapy in Patients With Acute Myeloid Leukaemia - Limited Effects in a Case Series

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2013English

Addition of Cladribine to Daunorubicin and Cytarabine Increases Complete Remission Rate After a Single Course of Induction Treatment in Acute Myeloid Leukemia. Multicenter, Phase III Study

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Lineage Switch From Acute Myeloid Leukaemia to T-Cell/Myeloid Mixed Phenotype Acute Leukaemia: First Report of an Adult Case

American Journal of Hematology
Hematology
2018English

Razoxane in Treatment of Acute Myeloid Leukaemia.

BMJ
1978English

Analysis of Transplantation Rate and Overall Treatment Efficacy by Age for Patients Aged 60 to 75 With Untreated Secondary Acute Myeloid Leukemia (AML) Given CPX-351 Liposome Injection Versus Conventional Cytarabine and Daunorubicin in a Phase III Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Dose Intensification of Daunorubicin and Cytarabine During Treatment of Adult Acute Lymphoblastic Leukemia

Cancer
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy